Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
allergan
3
×
biotech
boston blog main
clinical trials
crispr
3
×
life sciences
national blog main
san francisco blog main
alzheimer's disease
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
editas medicine
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
ipo
national
national top stories
new york blog main
new york top stories
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
What
bio
medicines
roundup
abbvie
acquisitions
alliance
announced
biotech
black
ceo
collabs
companies
continue
covid
daniel
deal
debut
diamond
diamond’s
editas
editing
exits
experimental
gene
genetic
gilead
gilead’s
help
indication
introduce
ipo
leading
life
mammoth
march
month
moves
ohana’s
o’day
pact
Language
unset
Current search:
allergan
×
abbvie
×
crispr
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
